At Last, Ranbaxy Gets Valsartan Ok From U.S. FDA; Now The Wait Is For Nexium And Valcyte (Update)
This article was originally published in PharmAsia News
Executive Summary
The Indian drug maker finally succeeded in getting an approval for the generic version of Diovan. Hope is now building for more big approvals sooner than later as market analysts see major gains.